Home > Clinical Trials
Check All Search

Saved trials

Recruiting
NCT05035277
AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation
360 Enrollment(s)
3 Study location(s)
Interventional (Phase III)
Aortic Stenosis
Completed
NCT03368196
DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein
12 Enrollment(s)
2 Study location(s)
Interventional (Phase I)
Adenocarcinoma, Gastric
Neoplasm, Breast
Recruiting
NCT05339672
Determining the Clinical Relevance of the Interaction Between Enzalutamide and the Opioid Morphine and the DOAC Edoxaban
26 Enrollment(s)
3 Study location(s)
Observational
Drug-drug Interaction
Completed
NCT04094662
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain
393 Enrollment(s)
40 Study location(s)
Interventional (Phase III)
Diabetic Peripheral Neuropathic Pain
Completed
NCT02841774
High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV
10 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
HIV Infection
Coronary Heart Disease
Active, not recruiting
NCT02564900
Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors
292 Enrollment(s)
14 Study location(s)
Interventional (Phase I)
Advanced Solid Tumors
Completed
NCT02871687
Effect of Statin Use on Aldosterone Secretion
103 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Healthy Subjects
Terminated
NCT03989713
Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD
11 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)